top of page
Resources
Health
Technology
Energy
Latest
Explainers
More
Use tab to navigate through the menu items.
Subscribe
Neuren Targets Breakthrough Treatment for Newborn Brain Injury with NNZ-2591
Neuren Pharmaceuticals (ASX: NEU) is expanding its pipeline with a new initiative: developing NNZ-2591 to treat (HIE), a severe brain...
Health
Mar 27
bottom of page
